12-Month Price Target For Acadia Pharmaceuticals Inc (NASDAQ:ACAD) Now Sits At 32
In last trading session, Acadia Pharmaceuticals Inc (NASDAQ:ACAD) saw 1.85 million shares changing hands with its beta currently measuring 0.65. Company’s recent per share price